A detailed history of Cannell & Co. transactions in Johnson & Johnson stock. As of the latest transaction made, Cannell & Co. holds 129,265 shares of JNJ stock, worth $18.7 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares
129,265
Previous 128,982 0.22%
Holding current value
$18.7 Million
Previous $20.1 Million 0.86%
% of portfolio
0.67%
Previous 0.71%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024

BUY
$145.6 - $158.88 $41,204 - $44,963
283 Added 0.22%
129,265 $20.3 Million
Q3 2023

Nov 14, 2023

SELL
$155.75 - $174.48 $768,314 - $860,709
-4,933 Reduced 3.68%
128,982 $20.1 Million
Q2 2023

Aug 09, 2023

SELL
$154.35 - $166.11 $268,569 - $289,031
-1,740 Reduced 1.28%
133,915 $22.2 Million
Q1 2023

May 08, 2023

SELL
$151.05 - $180.26 $243,492 - $290,579
-1,612 Reduced 1.17%
135,655 $21 Million
Q4 2022

Feb 03, 2023

SELL
$160.2 - $179.79 $83,304 - $93,490
-520 Reduced 0.38%
137,267 $24.2 Million
Q3 2022

Nov 02, 2022

SELL
$161.33 - $179.52 $6,453 - $7,180
-40 Reduced 0.03%
137,787 $22.5 Million
Q2 2022

Aug 08, 2022

SELL
$168.19 - $186.01 $349,498 - $386,528
-2,078 Reduced 1.49%
137,827 $24.5 Million
Q1 2022

May 10, 2022

BUY
$158.14 - $179.59 $120,818 - $137,206
764 Added 0.55%
139,905 $24.8 Million
Q4 2021

Feb 09, 2022

SELL
$155.93 - $173.01 $118,039 - $130,968
-757 Reduced 0.54%
139,141 $23.8 Million
Q3 2021

Nov 10, 2021

BUY
$161.5 - $179.47 $36,014 - $40,021
223 Added 0.16%
139,898 $22.6 Million
Q2 2021

Aug 09, 2021

SELL
$159.48 - $171.07 $6.04 Million - $6.48 Million
-37,898 Reduced 21.34%
139,675 $23 Million
Q1 2021

May 07, 2021

BUY
$153.07 - $170.48 $39,645 - $44,154
259 Added 0.15%
177,573 $29.2 Million
Q4 2020

Feb 11, 2021

SELL
$137.11 - $157.38 $107,357 - $123,228
-783 Reduced 0.44%
177,314 $27.9 Million
Q3 2020

Nov 12, 2020

SELL
$140.38 - $153.83 $9,124 - $9,998
-65 Reduced 0.04%
178,097 $26.5 Million
Q2 2020

Aug 07, 2020

SELL
$128.81 - $155.51 $80,506 - $97,193
-625 Reduced 0.35%
178,162 $25.1 Million
Q1 2020

May 05, 2020

SELL
$111.14 - $153.99 $309,524 - $428,862
-2,785 Reduced 1.53%
178,787 $23.4 Million
Q4 2019

Feb 10, 2020

SELL
$127.5 - $146.44 $4.28 Million - $4.91 Million
-33,550 Reduced 15.6%
181,572 $26.5 Million
Q3 2019

Nov 12, 2019

BUY
$126.95 - $142.14 $466,922 - $522,790
3,678 Added 1.74%
215,122 $27.8 Million
Q2 2019

Aug 12, 2019

SELL
$131.15 - $144.24 $314,104 - $345,454
-2,395 Reduced 1.12%
211,444 $29.5 Million
Q1 2019

May 14, 2019

BUY
$125.72 - $139.79 $1.28 Million - $1.42 Million
10,163 Added 4.99%
213,839 $29.9 Million
Q4 2018

Feb 11, 2019

SELL
$122.84 - $147.84 $91,024 - $109,549
-741 Reduced 0.36%
203,676 $26.3 Million
Q3 2018

Nov 05, 2018

BUY
$121.58 - $142.88 $45,957 - $54,008
378 Added 0.19%
204,417 $28.2 Million
Q2 2018

Aug 06, 2018

BUY
$119.4 - $131.76 $295,515 - $326,106
2,475 Added 1.23%
204,039 $24.8 Million
Q1 2018

May 09, 2018

SELL
$125.1 - $148.14 $392,063 - $464,270
-3,134 Reduced 1.53%
201,564 $25.8 Million
Q4 2017

Feb 13, 2018

SELL
$131.22 - $143.62 $1.5 Million - $1.65 Million
-11,464 Reduced 5.3%
204,698 $28.6 Million
Q3 2017

Nov 08, 2017

BUY
$129.47 - $135.38 $28 Million - $29.3 Million
216,162
216,162 $28.1 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $379B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Cannell & Co. Portfolio

Follow Cannell & Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cannell & Co., based on Form 13F filings with the SEC.

News

Stay updated on Cannell & Co. with notifications on news.